Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Azithromycin as Adjunctive Therapy for Uncomplicated Severe Acute Malnutrition

Trial Profile

Azithromycin as Adjunctive Therapy for Uncomplicated Severe Acute Malnutrition

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 24 Jan 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Azithromycin (Primary) ; Amoxicillin
  • Indications Malnutrition
  • Focus Therapeutic Use
  • Acronyms SAM

Most Recent Events

  • 11 Jan 2023 Results evaluated gut microbiomes in children treated with azithromycin versus amoxicillin for severe acute malnutrition, published in the American Journal of Tropical Medicine and Hygiene
  • 13 Jul 2022 Results published in the American Journal of Tropical Medicine and Hygiene
  • 03 Aug 2021 Phase of the study is changed from phase-4 to phase-3, and study model is changed from single group assignment to parallel assignment.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top